AddLife AB Stock price

Equities

ALIF B

SE0014401378

Biotechnology & Medical Research

Delayed Nasdaq Stockholm 07:59:50 2024-03-28 am EDT 5-day change 1st Jan Change
112 SEK +2.47% Intraday chart for AddLife AB +1.36% +2.38%
Sales 2023 9.68B 908M Sales 2024 * 10.16B 953M Capitalization 13.32B 1.25B
Net income 2023 190M 17.82M Net income 2024 * 302M 28.33M EV / Sales 2023 1.91 x
Net Debt 2023 5.19B 487M Net Debt 2024 * 4.47B 420M EV / Sales 2024 * 1.75 x
P/E ratio 2023
70.1 x
P/E ratio 2024 *
44.1 x
Employees 2,301
Yield 2023
0.46%
Yield 2024 *
0.78%
Free-Float 87.94%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.15%
1 week+1.36%
Current month+11.89%
1 month+12.00%
3 months+2.66%
6 months+75.69%
Current year+2.38%
More quotes
1 week
107.00
Extreme 107
113.70
1 month
94.65
Extreme 94.65
113.70
Current year
94.65
Extreme 94.65
118.40
1 year
54.75
Extreme 54.75
143.40
3 years
54.75
Extreme 54.75
395.00
5 years
52.25
Extreme 52.25
395.00
10 years
24.25
Extreme 24.25
395.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 21-12-31
Director of Finance/CFO - 21-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 20-12-31
Chairman 57 15-03-04
Director/Board Member 69 14-12-31
More insiders
Date Price Change Volume
24-03-28 112 +2.47% 67 357
24-03-27 109.3 -1.26% 163,798
24-03-26 110.7 +0.45% 136,122
24-03-25 110.2 +1.47% 68,397
24-03-22 108.6 -1.72% 100,737

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT

More quotes
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
109.3 SEK
Average target price
136.5 SEK
Spread / Average Target
+24.89%
Consensus
  1. Stock
  2. Equities
  3. Stock AddLife AB - Nasdaq Stockholm